- Home
- PLUR vs QNME Comparison
PLUR vs QNME Comparison
Compare PLUR & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLUR | QNME |
|---|---|---|
| Founded | 2001 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Integrated Freight & Logistics |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5M | 16.2M |
| IPO Year | 2001 | 2024 |
Fundamental Metrics
Financial Performance| Metric | PLUR | QNME |
|---|---|---|
| Price | $1.51 | $0.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 24.9K | ★ 803.9K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,336,000.00 | ★ $18,315,155.00 |
| Revenue This Year | $97.38 | N/A |
| Revenue Next Year | $293.97 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 309.82 | 42.28 |
| 52 Week Low | $1.41 | $0.30 |
| 52 Week High | $5.27 | $0.59 |
Technical Indicators
Market Signals| Indicator | PLUR | QNME |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 36.02 |
| Support Level | N/A | $0.30 |
| Resistance Level | $1.85 | $0.43 |
| Average True Range (ATR) | 0.13 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 8.70 | 15.21 |
Price Performance
Historical ComparisonAbout PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea.